Showing results (141-150 of 202) with videos related to

Sort By:
Pageof 21
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 25, 2007
Prognostic role of the extent of peritumoral vascular invasion in operable breast cancerM Colleoni, N Rotmensz, P Maisonneuve, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 3, 2019
Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019H J Burstein, G Curigliano, S Loibl, et al.
European Journal of Cancer (Oxford, England : 1990)|September 24, 1999
Prediction of response to primary chemotherapy for operable breast cancerM Colleoni, E Orvieto, F Nolé, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheterM Mandalà, G Curigliano, P Bucciarelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2007
Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapyM Colleoni, G Viale, D Zahrieh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
Recognizing features that are dissimilar in male and female breast cancer: expression of p21Waf1 and p27Kip1 using an immunohistochemical assayG Curigliano, M Colleoni, G Renne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 27, 2009
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-upM Colleoni, Z Sun, G Martinelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2003
Preoperative and perioperative chemotherapy with 5-fluorouracil as continuous infusion in operable breast cancer expressing a high proliferation fraction: cytotoxic treatment during the surgical phaseM Colleoni, G Curigliano, I Minchella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study GroupM Colleoni, M Bonetti, A S Coates, et al.
Pageof 21